Metformin is one of the most widely dispensed oral diabetes medications for good reason. It works great, lowering A1c 1-2% points, with an added benefit of dropping LDL cholesterol levels. It doesn’t cause hypoglycemia or weight gain and it is incredibly cheap. Many pharmacies offer a 3 month supply of this highly effective glucose-lowering medication for $10 or less, and that’s without insurance. This medication also seems to boost the diversity of the gut microbiota, in particularly increased levels of the very beneficial Akkermansia muciniphila.
However, it does have a few drawbacks. A small group of people on metformin will experience a B12 deficiency. This B12 deficiency may manifest as neuropathic pain or anemia.
Plus, a percentage of people will experience upset stomach, bloating, and diarrhea. People with these complaints will often respond better to the extended-release version (metformin XR), which isn’t any more expensive and it can be taken once a day. See our Mediation PocketCards for more info.
How prevalent is B12 Deficiency with metformin?

Currently, the ADA Standards have no clear recommendation for checking B12 for those on metformin, but it does note that long-term metformin use is associated with B12 deficiencies and that “measuring B12 levels should be considered for those with type 1 diabetes, peripheral neuropathy or unexplained anemia”.
To add to this, a study published this month in Human Nutrition and Metabolism, found the prevalence of B12 deficiency appears to be about 17% in people on metformin therapy. The highest rates of B12 deficiency were seen in those taking metformin for 2 years. Moreover, vitamin B12 deficiency is influenced by the occurrence and duration of diabetes.
They also measured the intake of vitamin B12 in the daily diet of the study participants. Those with lower vitamin B12 blood levels were also consuming less foods rich in vitamin B12 in their daily meal plan.
Recommendations for Regular B12 Monitoring and Replacement
The authors of this article suggest that routine monitoring for vitamin B12 serum levels is needed in people with T2DM, particularly when metformin is used for more than 2 years with a dose of over 1000 mg per day. They also recommend further studies are needed to assess the correlation between metformin duration and dose and patients with T2DM and other metabolic syndromes.
B12 replacement therapy
This article, nor the ADA Standards recommend dosing for B12 replacement therapy. However, based on several articles, including this 2005 Cochrane review, high-dose oral replacement (1 mg to 2 mg per day) for B12 deficiency, seems to be as effective as parenteral B12 administration for correcting anemia and neurologic symptoms.
Conclusion – Vitamin B12 deficiency is associated with worsening nerve pain and anemia. Testing B12 levels for those on long-term metformin therapy, especially for those taking more than 1000 mg of metformin a day seems like a reasonable approach. Increasing the intake of foods high in vitamin B12 and providing oral B12 replacement therapy of 1 mg to 2 mg a day, are both helpful interventions to boost B12 levels.
Resources from our Article Library
Plant Based Eating Resources and Recipes
Carbohydrate Counting Resource Page
Want to learn more about this topic? Enroll in our
Meds Management for Type 2 Standards | 1.5 CEs
Recorded & Ready to Watch!

Coach Beverly will highlight the key elements of the latest Medication Guidelines by AACE and ADA. We will explore clinical factors to consider when determining the best strategy to improve glucose management in people with type 2 diabetes and other co-conditions. There will be a special focus on cardiovascular risk reduction and renal protection.
Objectives:
- Describe the role of Diabetes Care and Education Specialists in stopping clinical inertia
- Discuss using the latest ADA and AACE Guidelines to determine the best therapeutic approach.
- Using the ADA and AACE Guidelines, describe strategies to initiate and adjust injectable therapy.
Enroll in the entire
Level 2 | Standards of Care Intensive Series | 20 CEs | $199
2022 Updates Airs March 17 – May 26, 2022

This bundle is specifically designed for healthcare professionals who want to learn more about the ADA Standards of Diabetes Care for their clinical practice or for those who are studying for the BC-ADM or the CDCES certification exam.
- Recorded on December 15, 2021 – Hyperglycemic Crises, DKA & HHS Standards | 1.0 CE
- Recorded on December 21, 2021 – Assessing and Promoting Well-Being: From Population Health to a Person-Centered Approach Standards | 1.5 CEs
- Recorded on February 3, 2022 – ADA Standards of Care | 2.0 CEs
- Recorded on March 17, 2022 – Setting up a Successful Diabetes Program 1.5 CEs
- Recorded on March 22, 2022 – Lower Extremity Assessment 1.5 CEs
- Recorded on March 24, 2022 – Meds Management for Type 2 – 1.5 CEs
- April 26, 2022 – Microvascular Complications, Eye, Kidney Nerve Disease 1.5 CEs
- April 28, 2022 – Critical Assessment of Diabetes Patient 2.0 CEs
- May 10, 2022 – Cardiovascular Disease and Diabetes Standards 1.5 CEs
- May 12, 2022 – Older Adults and DIabetes 1.5 CEs
- May 17, 2022 – Tots to Teens – Diabetes Standards 1.5 CEs
- May 19, 2022 – Pregnancy and Diabetes 1.5 CEs
- May 26, 2022 – Hospital and Hyperglycemia 1.5 CEs
Accreditation: Diabetes Education Services is an approved provider by the California Board of Registered Nursing, Provider 12640, and Commission on Dietetic Registration (CDR), Provider DI002. Since these programs are approved by the CDR it satisfies the CE requirements for the CDCES regardless of your profession.
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
[yikes-mailchimp form=”1″]The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.